Literature DB >> 21301545

The epidemiology of psychotropic drug use in Canada.

R Cooperstock.   

Abstract

The problems and limitations of the two primary methods of assessing prescription drug consumption are discussed. The latest available consumption data on tranquillizers and/or psychotropics from Ontario, Quebec, and Saskatchewan are presented. Total per capita consumption of all drugs has risen steadily while the proportion of all prescriptions accounted for by psychotropic drugs has remained quite consistent. Studies concerned with the patterns of psychotropic drug use are discussed. These identify the high-risk populations as the chronically ill, the elderly, women and the institutionalized.

Entities:  

Year:  1978        PMID: 21301545      PMCID: PMC2379485     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  6 in total

1.  Mood-modifying drugs prescribed in a Canadian city: hidden problems.

Authors:  R Cooperstock; M Sims
Journal:  Am J Public Health       Date:  1971-05       Impact factor: 9.308

2.  Cross-national study of the extent of anti-anxiety-sedative drug use.

Authors:  M B Balter; J Levine; D I Manheimer
Journal:  N Engl J Med       Date:  1974-04-04       Impact factor: 91.245

3.  Prescription of psychotropic drugs by general practitioners. 1. General.

Authors:  I L Rowe
Journal:  Med J Aust       Date:  1973-03-24       Impact factor: 7.738

4.  A comparison of general drug utilization in a metropolitan community with utilization under a drug prepayment plan.

Authors:  M R Greenlick; B J Darsky
Journal:  Am J Public Health Nations Health       Date:  1968-11

5.  Psychotropic drug use in the Boston area. A report from the Boston Collaborative Drug Surveillance Program.

Authors:  D J Greenblatt; R I Shader; J Koch-Weser
Journal:  Arch Gen Psychiatry       Date:  1975-04

6.  Psychotropic drug use among women.

Authors:  R Cooperstock
Journal:  Can Med Assoc J       Date:  1976-10-23       Impact factor: 8.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.